Advertisement

Organisation › Details
Mesa Biotech Inc.
Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech's patented technology expands the availability of gold standard nucleic acid PCR amplification to point-of-care diagnostics. The company is based in San Diego, California and has approximately 500 employees and revenues in 2020 of approximately $45 million. Mesa Biotech's Accula™ Flu A/Flu B, RSV and Strep A tests have obtained 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waivers from the U.S. Food and Drug Administration (FDA). Additionally, the Accula System has received Emergency Use Authorization (EUA) from the FDA for SARS-CoV-2 in vitro diagnostic testing and is now available for use in patient care settings, providing results within 30 minutes, with higher accuracy than other rapid tests on the market. *
![]() |
Start | 2021-01-19 existent |
Group | Thermo Fisher (Group) | |
![]() |
Industry | molecular diagnostics |
Industry 2 | PCR test (clinical diagnostics) | |
![]() |
Person | Chakravarty, Ingo (Mesa Biotech 202101 CEO) |
![]() |
Region | San Diego, CA |
Country | United States (USA) | |
City | n. a. San Diego, CA | |
Address record changed: 2021-01-19 | ||
Basic data | Employees | D: 101 to 500 (2021-01-19) |
Currency | USD | |
Annual sales | 45,000,000 (sales, annual (2020) 2020-12-31) | |
* Document for �About Section�: Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA. | ||
Record changed: 2021-01-19 |
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
More documents for Thermo Fisher (Group)
- [1] Thermo Fisher Scientific Inc.. (1/4/22). "Press Release: Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference". Waltham, MA....
- [2] Bico Group AB. (11/15/21). "Press Release: Cellenion Announces Co-marketing Agreement for Single Cell Mass Spectrometry-based Proteomics Analysis"....
- [3] Thermo Fisher Scientific Inc.. (9/23/21). "Press Release: First Net Zero Mass Spectrometer Launched to Support Greener Future". Bremen....
- [4] Thermo Fisher Scientific Inc.. (9/8/21). "Press Release: Next-Generation Nano-, Capillary- and Micro-Flow LC Systems Enhance Productivity and Performance". Germering....
- [5] Thermo Fisher Scientific Inc.. (7/7/21). "Press Release: Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics". San José, CA & Davis, CA....
- [6] IonSense, Inc.. (6/3/21). "Press Release: IonSense Appoints Jeff Zonderman as CEO as It Expands Its Direct Analysis Mass Spectrometry Technology to New Platforms". Saugus, MA....
- [7] Knauer Wissenschaftliche Geräte GmbH. (3/31/21). "Press Release: Carsten Losch Joins General Management at Knauer"....
- [8] Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth....
- [9] Thermo Fisher Scientific Inc.. (2/17/21). "Press Release: Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs". Waltham, MA....
- [10] Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top